989 related articles for article (PubMed ID: 32621569)
1. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
[TBL] [Abstract][Full Text] [Related]
2. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
[TBL] [Abstract][Full Text] [Related]
3. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to 'Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)' [Eur J Heart Fail 2020;22:1504-1524].
Eur J Heart Fail; 2021 Feb; 23(2):345. PubMed ID: 33783083
[No Abstract] [Full Text] [Related]
5. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Lyon AR; López-Fernández T; Couch LS; Asteggiano R; Aznar MC; Bergler-Klein J; Boriani G; Cardinale D; Cordoba R; Cosyns B; Cutter DJ; de Azambuja E; de Boer RA; Dent SF; Farmakis D; Gevaert SA; Gorog DA; Herrmann J; Lenihan D; Moslehi J; Moura B; Salinger SS; Stephens R; Suter TM; Szmit S; Tamargo J; Thavendiranathan P; Tocchetti CG; van der Meer P; van der Pal HJH;
Eur Heart J; 2022 Nov; 43(41):4229-4361. PubMed ID: 36017568
[No Abstract] [Full Text] [Related]
6. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Lyon AR; López-Fernández T; Couch LS; Asteggiano R; Aznar MC; Bergler-Klein J; Boriani G; Cardinale D; Cordoba R; Cosyns B; Cutter DJ; de Azambuja E; de Boer RA; Dent SF; Farmakis D; Gevaert SA; Gorog DA; Herrmann J; Lenihan D; Moslehi J; Moura B; Salinger SS; Stephens R; Suter TM; Szmit S; Tamargo J; Thavendiranathan P; Tocchetti CG; van der Meer P; van der Pal HJH;
Eur Heart J Cardiovasc Imaging; 2022 Sep; 23(10):e333-e465. PubMed ID: 36017575
[No Abstract] [Full Text] [Related]
7. Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
Bergler-Klein J; Rainer PP; Wallner M; Zaruba MM; Dörler J; Böhmer A; Buchacher T; Frey M; Adlbrecht C; Bartsch R; Gyöngyösi M; Fürst UM
Wien Klin Wochenschr; 2022 Sep; 134(17-18):654-674. PubMed ID: 35507087
[TBL] [Abstract][Full Text] [Related]
8. Competency-based cardiac imaging for patient-centred care. A statement of the European Society of Cardiology (ESC). With the contribution of the European Association of Cardiovascular Imaging (EACVI), and the support of the Association of Cardiovascular Nursing & Allied Professions (ACNAP), the Association for Acute CardioVascular Care (ACVC), the European Association of Preventive Cardiology (EAPC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the European Heart Rhythm Association (EHRA), and the Heart Failure Association (HFA) of the ESC.
Westwood M; Almeida AG; Barbato E; Delgado V; Dellegrottaglie S; Fox KF; Gargani L; Huber K; Maurovich-Horvat P; Merino JL; Mindham R; Muraru D; Neubeck L; Nijveldt R; Papadakis M; Pontone G; Price S; Rosano GMC; Rossi A; Sade LE; Schulz-Menger J; Weidinger F; Achenbach S; Petersen SE
Eur Heart J Cardiovasc Imaging; 2023 Oct; 24(11):1415-1424. PubMed ID: 37622662
[TBL] [Abstract][Full Text] [Related]
9. Competency-based cardiac imaging for patient-centred care. A statement of the European Society of Cardiology (ESC). With the contribution of the European Association of Cardiovascular Imaging (EACVI), and the support of the Association of Cardiovascular Nursing & Allied Professions (ACNAP), the Association for Acute CardioVascular Care (ACVC), the European Association of Preventive Cardiology (EAPC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the European Heart Rhythm Association (EHRA), and the Heart Failure Association (HFA) of the ESC.
Westwood M; Almeida AG; Barbato E; Delgado V; Dellegrottaglie S; Fox KF; Gargani L; Huber K; Maurovich-Horvat P; Merino JL; Mindham R; Muraru D; Neubeck L; Nijveldt R; Papadakis M; Pontone G; Price S; Rosano GMC; Rossi A; Sade LE; Schulz-Menger J; Weidinger F; Achenbach S; Petersen SE
Eur Heart J; 2023 Dec; 44(45):4771-4780. PubMed ID: 37622660
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
[TBL] [Abstract][Full Text] [Related]
11. Echocardiography and Cardio-Oncology.
Negishi T; Miyazaki S; Negishi K
Heart Lung Circ; 2019 Sep; 28(9):1331-1338. PubMed ID: 31230869
[TBL] [Abstract][Full Text] [Related]
12. European Society of Cardiology Core Curriculum for cardio-oncology.
López-Fernández T; Farmakis D; Ameri P; Asteggiano R; de Azambuja E; Aznar M; Barac A; Bayes-Genis A; Bax JJ; Bergler-Klein J; Boriani G; Celutkiene J; Coats A; Cohen-Solal A; Córdoba R; Cosyns B; Filippatos G; Fox K; Gulati G; Inciardi RM; Lee G; Mamas MA; Novo G; Plummer C; Psyrri A; Rakisheva A; Suter T; Tini G; Tocchetti CG; Toutouzas K; Wilhelm M; Metra M; Lyon AR; Rosano GMC
Eur J Heart Fail; 2024 Apr; 26(4):754-771. PubMed ID: 38059343
[TBL] [Abstract][Full Text] [Related]
13. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GYH; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM;
Eur Heart J; 2016 Sep; 37(36):2768-2801. PubMed ID: 27567406
[No Abstract] [Full Text] [Related]
14. Strain Imaging in Cardio-Oncology.
Liu JE; Barac A; Thavendiranathan P; Scherrer-Crosbie M
JACC CardioOncol; 2020 Dec; 2(5):677-689. PubMed ID: 34396282
[TBL] [Abstract][Full Text] [Related]
15. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
Tajiri K; Aonuma K; Sekine I
Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
[TBL] [Abstract][Full Text] [Related]
16. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
[TBL] [Abstract][Full Text] [Related]
17. Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice.
Tini G; Cuomo A; Battistoni A; Sarocchi M; Mercurio V; Ameri P; Volpe M; Porto I; Tocchetti CG; Spallarossa P
Int J Cardiol; 2022 Feb; 349():134-137. PubMed ID: 34848212
[TBL] [Abstract][Full Text] [Related]
18. Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology.
Nobre Menezes M; Tavares da Silva M; Magalhães A; Melica B; Toste JC; Calé R; Almeida M; Fiuza M; Infante de Oliveira E
Rev Port Cardiol; 2024 Jan; 43(1):35-48. PubMed ID: 37482119
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity of cancer chemotherapy in clinical practice.
Jain D; Aronow W
Hosp Pract (1995); 2019 Feb; 47(1):6-15. PubMed ID: 30270693
[TBL] [Abstract][Full Text] [Related]
20. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GY; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM; Zamorano JL; Aboyans V; Achenbach S; Agewall S; Badimon L; Barón-Esquivias G; Baumgartner H; Bax JJ; Bueno H; Carerj S; Dean V; Erol Ç; Fitzsimons D; Gaemperli O; Kirchhof P; Kolh P; Lancellotti P; Lip GY; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Roffi M; Torbicki A; Vaz Carneiro A; Windecker S; ; ;
Eur J Heart Fail; 2017 Jan; 19(1):9-42. PubMed ID: 27565769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
